A. J. Kazimi - SEC Form 4 Insider Trading Activity

Summary

Updated Aug 3, 2026

A. J. Kazimi is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $10K. Historical track record: 4/5 stars across 184 tracked purchases.

Profile

A. J. Kazimi

A. J. Kazimi holds the role of Chairman and CEO at CUMBERLAND PHARMACEUTICALS INC (CPIX). Kazimi has reported 15 insider filings with the SEC since 2024. The most recent filing was in March 2026.

RoleChairman and CEO, Director, 10% Owner
Notability50/100

Board memberships

Reported roles

Awards & honors

Track Record

InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.

InsiderAlpha rating★★★★☆ (4/5)
Total purchases tracked184
Purchases with forward-return data184
30-day win rate52%
90-day win rate43%
Avg 5-day return+1.46%
Avg 30-day return+7.37%
Avg 90-day return+47.96%
Best 30-day return+121.70%

Trading Pattern

InsiderAlpha's records for A. J. Kazimi go back to 2024: 15 primary Form 4 filings, an average of 5.0 per year. The typical open-market purchase is $56 (184 buys totaling $10K). The largest single buy on record is $108 of CPIX in 2024. 141 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.

Career & Filing History

Every role A. J. Kazimi has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-03-18CPIXCUMBERLAND PHARMACEUTICALS INCF - Tax withholding / forfeiture5.8K$3.06$18K
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]18$2.41$43
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]18$2.17$39
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]18$2.21$40
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]18$2.10$38
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]17$1.96$33
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]17$1.99$34
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]17$2.01$34
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]17$1.98$34
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]17$2.17$37
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]16$2.15$34
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]16$2.17$35
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]16$1.99$32
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]16$2.06$33
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]16$2.11$34
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]13$2.19$28
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]13$2.27$30
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]13$2.53$33
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]13$2.82$37
2025-12-01CPIXCUMBERLAND PHARMACEUTICALS INCJ - Other acquisition / disposition [10b5-1]13$2.80$36

Most Active Insiders Right Now

A. J. Kazimi has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.

More Notable Insiders

Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:

Frequently Asked Questions

Who is A. J. Kazimi?

A. J. Kazimi holds the role of Chairman and CEO at CUMBERLAND PHARMACEUTICALS INC (CPIX). Kazimi has reported 15 insider filings with the SEC since 2024. The most recent filing was in March 2026.…

Has A. J. Kazimi been buying or selling stock?

Recorded transactions: 184 open-market purchases ($10K) and 0 open-market sales across all tracked filings.

How accurate is A. J. Kazimi's historical track record?

Across 184 tracked purchases, A. J. Kazimi averaged +7.4% avg 30-day return with a 52% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.

Where can I see all of A. J. Kazimi's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live A. J. Kazimi profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.